Latent TB Infection and Screening Programme. Johan van Wijgerden London TB Programme Manager

Similar documents
Diabetes in London. Dr Jane Fryer. Date

CHAIN Data Analysis. January March 2017 (Quarter 4)

Access to dental services and oral health for residents in the borough of Barnet

Tuberculosis in London Annual review (2015 data) Data from 2000 to 2015

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

Breast Screening Data Stephen Scott Head of Informatics LCA

LONDON BOROUGH OF HAVERING

Malaria in London: Review of imported malaria cases. Data from 2000 to 2012

Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set

New guidelines for HIV testing and areas where wider HIV testing policies should be considered.

Analysis of One- Year Cancer Survival Rates

Report to Health and Well- Being Board on Childhood Immunisation Programmes in Barnet 14 th September 2017/18

Analysis of One- Year Cancer Survival Rates

Analysis of One- Year Cancer Survival Rates

Analysis of One- Year Cancer Survival Rates

Analysis of One- Year Cancer Survival Rates

Northwestern Polytechnic University

Tuberculosis Among Children in the Republic of the Marshall Islands

Chapter 7 Tuberculosis (TB)

#AskAboutAsthma: from vision to reality

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Interventions to improve screening for latent TB: effectiveness and outcomes

Children and Young Peoples Oral Health in Barnet

Islington JSNA 2010/11 Healthy Eating

Latent tuberculosis infection

Proposed Regs.pdf

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Tuberculosis Tools: A Clinical Update

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

Annual Epidemiological Spotlight on HIV in London data

Management of Pediatric Tuberculosis in New Jersey

2017/2018 Annual Volunteer Tuberculosis Notice

A good death with dementia. Dr Juliette Brown Dr Cate Bailey East London NHS Foundation Trust; for NHSE London End of Life Clinical Network

Challenges for the Lung Cancer Pathway Group

Infections What is new and what is important?

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Paving the way in dementia diagnosis: Lessons learnt for future planning 28 April 2015

Thorax Online First, published on December 8, 2009 as /thx

Tuberculosis in Wales Annual Report 2014

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis in Wales Annual Report 2015

Key Messages. Acknowledgements. Authors. Written by Neeraj Malhotra and Dr Bobbie Jacobson

London Smoking Cessation Transformation Programme

Excellent Psychological Care for those affected by cancer

Annual surveillance report 2015

Healthy London Partnership

Communicable Disease Control Manual Chapter 4: Tuberculosis

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Diagnosis of tuberculosis in children

INDEX CASE INFORMATION

New Entrant Screening and Latent TB Get screened and find out if you have TB infection before you develop TB disease!

A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment

Registered childcare providers and places in England, 30 September October 2004

Royal Borough of Greenwich: joint strategic needs assessment for prevention and treatment of harmful drinking

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

VENOUS THROMBOEMBOLISM (VTE) IN CANCER PATIENTS CANCER, CHEMOTHERAPY AND CLOTS

Tuberculosis in Wales Annual Report 2013

Getting serious about preventing cardiovascular disease

VENOUS THROMBOEMBOLISM (VTE) IN CANCER PATIENTS CANCER, CHEMOTHERAPY AND CLOTS

UC DavisTB Screening Requirement: How to submit your TB Health Assessment Form

Tuberculosis & Refugees in Philadelphia

T uberculosis is increasing across the UK and is a particular

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Dementia needs assessment

New NICE guideline updates recommendations for diagnosing latent tuberculosis

Tuberculosis Intensive

Contact Investigation and Prevention in the USA

Annual surveillance report 2016

2016 Annual Tuberculosis Report For Fresno County

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Monitoring & evaluation LTBI management in the Netherlands. Key lessons.

Isoniazid preventive therapy for HIV+:

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations

TB in the Patient with HIV

Latent Tuberculosis Best Practices

These recommendations will remain in effect until the national shortage of PPD solution has abated.

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

TB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

A few things to note:

NIHR HTA Programme. 09 July 2013

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Trust Guideline for the Prevention of Tuberculosis and Management of Tuberculosis Exposure in Health Care Workers

Diagnosis & Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection

Tuberculosis (TB) Fundamentals for School Nurses

Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -

Algorithmic Approaches to Child TB Management in Resource-limited Settings

No child should feel alone. Making a difference OUR IMPACT IN LONDON 2017/18

Clinical diagnosis and management of tuberculosis, and measures for its prevention and control

Other NCAS Providers. Locality Region Organisation responsible Helpline/Contact number. Barking and Dagenham London Pohwer ICAS

Ongoing Research on LTBI and Research priorities in India

Healthcare Requirements for Health Science Students To Be Completed by your Primary Healthcare Provider

The clinical utility of the urine based lateral flow lipoarabinomannan (LF-LAM) assay in HIV infected adults in Myanmar.

Tuberculosis Populations at Risk

A pilot study measuring the kinetic profile of IP-10 over the first 14 days of PTB chemotherapy

Transcription:

Latent TB Infection and Screening Programme Johan van Wijgerden London TB Programme Manager

TB case rates by upper tier local authority of residence, London, 2016

TB case rates by Middle Super Output Area/ward of residence, London, 2016

Wandsworth

Wandsworth Annual TB incidence rate, 2002-2016

Outcomes at 12 months in drugsensitive cohort, London, cases diagnosed in 2015* Outcome at 12 months n % Completed 1,700 86.6 Died 63 3.2 Lost to follow up 66 3.4 Still on treatment 97 4.9 Treatment stopped 20 1.0 Not evaluated 16 0.8 Total 1,962 *excludes rifampicin-resistant TB, and patients with CNS, spinal, miliary or cryptic disseminated disease

Outcomes at 24 months for patients with rifampicin-resistant TB, London, cases diagnosed in 2014 Outcome at 24 months n % Completed 13 57 Completed at 12 months 2 9 Died 1 4 Still on treatment 4 17 Missing (LFU at 12 months) 3 13 Total 23

Active TB vs. Latent TB Active TB = sick (clinical diagnosis of tuberculosis) Latent TB = not sick, but infected (no symptoms, but a blood test shows that you ve been exposed to the organism)

Diagnosis and Treatment of LTBI Latent TB is diagnosed when a patient has a positive Interferon Gamma Release Assay (IGRA) or a strongly positive tuberculin skin test in the absence of illness. Clinical assessment and CXR (+/- CT Scan) are used to rule out active TB Latent TB is treated with a 3 month course of two antibiotics, Isoniazid and Rifampicin, or a 6 month course of Isoniazid Those with latent TB have a 10 15 % lifetime risk of going onto develop active TB disease Diagnosis and treatment of latent TB infection is recommended for certain populations (see NICE) so that the burden of TB disease is reduced

Iceberg Model CXR screening PTB PTB - preclinical LTBI testing Awareness raising Latent TB infection 16

LTBI Eligibility Eligibility criteria for LTBI testing a) Born or spent >6 m in high TB incidence country ( 150/100,000 or Sub Saharan Africa) b) Entered the UK within the last 5 years (including entry via other countries) c) Aged between 16-35 years. d) No history of TB or LTBI, not previously screened for LTBI in UK Check website: https://www.gov.uk/guidance/tuberculosis-screening

Latent Tuberculosis Infection (LTBI) testing and treatment algorithm 1 Full eligibility criteria a) Born or spent >6 months in high TB incidence country (150 cases per 100,000 or more/sub-saharan Africa); b) Entered the UK within the last 5 years (including where entry was via other countries (e.g. within EU/EEA); c) Aged 16-35 years; d) No history of TB either treated or untreated; e) Never screened for TB in UK. Also review indication for LTBI screening using NICE guidance (e.g. if outside age group). 2 TB contacts should be referred to the local TB service. TB suggestive symptoms include a) Cough> 3 weeks; b) Haemoptysis (cough with blood); c) Night sweats; d) Unexplained weight loss; e) Unexplained fever; f) Lymph node swelling (especially cervical). 3 The invitation letter advises patients to seek clinical care if they have symptoms of TB 4 The recommended investigations prior to referral will depend on local arrangements, but might include CXR and sputum collection as appropriate NB- colours of the boxes denote location and responsibilities: blue- systematic identification mechanism; Green- Primary Care; Orange- Secondary Care 5 Also offer HIV test according to BHIVA/HPA recommendations and consider hepatitis B/C testing where appropriate.

Clinical follow up LTBI ve patients: inform and advise LTBI +ve patients: clinical work up before treatment (to exclude active TB disease). Referral of LTBI +ve patients to TB Nursing service

London Numbers (Q1-Q3 2017-18) CCG Location Planned Activity Q1-Q3 Q1 Q2 Q3 Total Percentage NHS Brent CCG 1260 285 245 445 975 77 NHS Central London(Westminster) CCG 135 1 1 0 2 1 NHS City And Hackney CCG 582 4 9 1 14 2 NHS Croydon CCG 0 8 7 47 62 n/a NHS Ealing CCG 942 65 52 148 265 28 NHS Greenwich CCG 918 188 386 114 688 75 NHS Hammersmith & F.. 159 1 0 0 1 1 NHS Harrow CCG 399 102 53 73 228 57 NHS Hillingdon CCG 687 12 30 7 49 7 NHS Hounslow CCG 627 141 112 105 358 57 NHS Lambeth CCG 468 7 3 30 40 9 NHS Lewisham CCG 636 4 5 3 12 2 NHS Merton CCG 375 20 19 22 61 16 NHS Newham CCG 2790 579 453 251 1283 46 NHS Southwark CCG 270 2 0 0 2 1 NHS Tower Hamlets CCG 918 2 4 7 13 1 NHS Waltham Forest CCG 825 10 10 11 31 4 NHS Wandsworth CCG 600 31 38 49 118 20 NHS West London CCG 174 1 0 0 1 1 Total 12765 1464 1427 1313 4204 33

Questions